33 results
8-K
EX-99.1
SNOA
Sonoma Pharmaceuticals Inc.
9 Apr 24
Regulation FD Disclosure
7:30am
management in dermatologic and plastic su rgery procedures, see https://sonomapharma.com/wp - content/uploads/2020/08/Topical - Stabilized - HOCL
8-K
EX-99.1
SNOA
Sonoma Pharmaceuticals Inc.
2 Apr 24
Sonoma Pharmaceuticals, Inc. Investor Presentation April 2024
7:30am
Topical stabilized hypochlorous acid: The future gold standard for wound care and scar management in dermatologic and plastic su rgery procedures, see
8-K
EX-99.1
SNOA
Sonoma Pharmaceuticals Inc.
10 Jan 24
Sonoma Pharmaceuticals, Inc. Investor Presentation January 2024
7:30am
for wound care and scar management in dermatologic and plastic su rgery procedures, see https://sonomapharma.com/wp - content/uploads/2020/08/Topical
8-K/A
EX-99.1
SNOA
Sonoma Pharmaceuticals Inc.
11 Oct 23
Sonoma Pharmaceuticals, Inc. Investor Presentation October 2023
4:30pm
for wound care and scar management in dermatologic and plastic su rgery procedures, see https://sonomapharma.com/wp - content/uploads/2020/08/Topical
8-K
EX-99.1
SNOA
Sonoma Pharmaceuticals Inc.
11 Oct 23
Sonoma Pharmaceuticals, Inc. Investor Presentation October 2023
7:30am
for wound care and scar management in dermatologic and plastic su rgery procedures, see https://sonomapharma.com/wp - content/uploads/2020/08/Topical
8-K
EX-99.1
f6m2bdr59br22 fgpwjt
10 May 23
Regulation FD Disclosure
7:30am
8-K
EX-10.1
2oyrr2he2wfurtfhr
20 Jan 22
Entry into a Material Definitive Agreement
5:10pm
8-K
EX-99.1
9jek1egr1as4l5
6 Jan 22
Regulation FD Disclosure
4:00pm
8-K
EX-10.1
5c6n7p0 s9
31 Mar 21
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.1
8ka1y 9pi1n9
4 Mar 21
Regulation FD Disclosure
4:01pm
8-K
EX-99.1
d5zx6 420epu
11 Jan 21
Regulation FD Disclosure
4:05pm
424B5
r50iz4c
20 Nov 18
Prospectus supplement for primary offering
4:06pm